What Happened?
Shares of wellness products company Nature’s Sunshine (NASDAQ: NATR)
fell 17.7% in the afternoon session after the company reported second-quarter 2026 results that missed Wall Street's expectations and lowered its full-year revenue forecast. The wellness products company's revenue of $117 million came in 5.4% below analyst estimates, while its adjusted earnings per share of $0.21 missed by a wider margin of 22.2%.
Compounding the weak quarterly performance, Nature's Sunshine also cut its full-year revenue guidance to $495 million at the midpoint, a 2.5% decrease from its previous forecast, and below analysts' projections. This combination of a current-quarter miss and a dimmer outlook for the remainder of the year signaled to investors that the company is facing significant headwinds.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Nature's Sunshine? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Nature's Sunshine’s shares are not very volatile and have only had 9 moves greater than 5% over the last year. Moves this big are rare for Nature's Sunshine and indicate this news significantly impacted the market’s perception of the business.
The biggest move we wrote about over the last year was 9 months ago when the stock gained 26.3% on the news that the company reported strong third-quarter 2025 results that beat Wall Street's expectations and raised its full-year guidance. The wellness products company announced that its sales increased 12% year-over-year to $128.3 million, topping analyst estimates.
Profitability also saw a significant boost, with adjusted earnings of $0.36 per share, more than double Wall Street's forecast of $0.16. The company's operational efficiency improved, with its operating margin expanding to 7% from 4.6% in the same quarter last year. In light of these positive results, Nature's Sunshine lifted its full-year 2025 forecast for both sales and adjusted EBITDA, signaling confidence in its continued business momentum.
Nature's Sunshine is down 20.3% since the beginning of the year, and at $16.71 per share, it is trading 39.9% below its 52-week high of $27.80 from March 2026. Despite the year-to-date decline, investors who bought $1,000 worth of Nature's Sunshine’s shares 5 years ago would now be looking at an investment worth $1,005.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
